Literature DB >> 23828465

Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.

James Jay Augsburger1, Zélia Maria Corrêa, Nikolaos Trichopoulos.   

Abstract

PURPOSE: Determine whether cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy (FNAB) is a significant prognostic factor for death from metastasis.
METHODS: Retrospective analysis of cases of clinically diagnosed uveal melanoma evaluated by fine-needle aspiration biopsy from 1980 to 2006. Main outcome evaluated was death from metastasis. Associations between baseline clinical variables and cytopathologic classification were evaluated using cross-tabulation. Prognostic significance of cytopathologic classification was evaluated by Kaplan-Meier and Cox proportional hazards analysis.
RESULTS: Of 302 studied biopsies, 260 (86.1%) yielded sufficient cells for cytopathologic classification. Eighty of the 260 patients who had a sufficient specimen have already died (P=0.021), 69 from metastatic uveal melanoma. Cell type assigned by cytopathology was strongly associated with metastasis/metastatic death in this series (P=0.0048). Multivariate analysis showed cytopathologic classification to be an independently significant prognostic factor for metastatic death (P=0.0006). None of the 42 patients whose tumor yielded insufficient aspirates (sampled in at least two sites) have developed metastasis or died of metastasis thus far.
CONCLUSION: In this series, cytopathology of fine-needle aspiration biopsy samples obtained from uveal melanomas was strongly prognostic of death from metastasis. Insufficiently aspirates (2 or more sites sampled) proved to be prognostic of a favorable outcome (i.e., not developing metastasis).

Entities:  

Mesh:

Year:  2013        PMID: 23828465     DOI: 10.1590/s0004-27492013000200004

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  7 in total

1.  Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy.

Authors:  James J Augsburger; Zélia M Corrêa; Bret D Augsburger
Journal:  Am J Ophthalmol       Date:  2014-11-05       Impact factor: 5.258

Review 2.  Choroidal biopsies; a review and optimised approach.

Authors:  R N Hussain; B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

3.  Instrument Gauge and Type in Uveal Melanoma Fine Needle Biopsy: Implications for Diagnostic Yield and Molecular Prognostication.

Authors:  Lindsay K Klofas; Carley M Bogan; Alice C Coogan; Stephen J Schultenover; Vivian L Weiss; Anthony B Daniels
Journal:  Am J Ophthalmol       Date:  2020-08-18       Impact factor: 5.258

Review 4.  Clinical application of genetic testing for posterior uveal melanoma.

Authors:  Victoria J Schopper; Zelia M Correa
Journal:  Int J Retina Vitreous       Date:  2016-02-01

5.  Survival analysis following enucleation for uveal melanoma.

Authors:  Guy S Negretti; Sarega Gurudas; Beatrice Gallo; Bertil Damato; Amit K Arora; Sobha Sivaprasad; Mandeep S Sagoo
Journal:  Eye (Lond)       Date:  2021-08-02       Impact factor: 4.456

6.  Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications.

Authors:  Zelia M Correa; James J Augsburger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-24       Impact factor: 3.117

Review 7.  Recent advancements in the management of retinoblastoma and uveal melanoma.

Authors:  Amy C Schefler; Ryan S Kim
Journal:  F1000Res       Date:  2018-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.